Literature DB >> 6200481

Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo.

P Giulidori, M Galli-Kienle, E Catto, G Stramentinoli.   

Abstract

S-Adenosylmethionine (AdoMet) is metabolized through three main pathways, i.e. (a) transfer of its methyl group to a variety of methyl acceptors, (b) decarboxylation followed by aminopropylation leading to polyamine synthesis, and (c) cleavage of the bond between the sulfur atom and carbon 4 of the amino acid chain, resulting in formation of methylthioadenosine and homoserine thiolactone. In this study the metabolism of AdoMet through these pathways was studied after intravenous administration to rats of [1-14C]-, [3,4-14C]-, [methyl-14C]-, and [35S]AdoMet at various doses. The relative utilization of AdoMet and methionine was also investigated. The results show that intravenously administered AdoMet is efficiently metabolized in vivo up to the highest tested dose (250 mumol X kg-1 body weight), about two-thirds of the metabolized compound being utilized via transmethylation and cleavage to methylthioadenosine and one-third via decarboxylation. The efficient incorporation of the methyl group of AdoMet into muscle creatine indicates unambiguously that the compound is taken up and metabolized by the liver. Moreover, intravenously administered AdoMet is shown to be a better precursor than methionine both in creatine formation and in the utilization of the sulfur atom in transsulfuration reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200481

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis.

Authors:  E Pisi; G Marchesini
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Recent advances in the biochemistry of polyamines in eukaryotes.

Authors:  A E Pegg
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

3.  S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha.

Authors:  W H Watson; Y Zhao; R K Chawla
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

Review 4.  Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.

Authors:  S Wagner; H U Lautz; M J Müller; F W Schmidt
Journal:  Klin Wochenschr       Date:  1991-02-06

Review 5.  Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma.

Authors:  Rosa M Pascale; Claudio F Feo; Diego F Calvisi; Francesco Feo
Journal:  Transl Gastroenterol Hepatol       Date:  2018-06-29

6.  A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.

Authors:  Timothy R Morgan; Kathryn Osann; Teodoro Bottiglieri; Neville Pimstone; John C Hoefs; Ke-Qin Hu; Tarek Hassanein; Thomas D Boyer; Lorene Kong; Wen-Pin Chen; Ellen Richmond; Rachel Gonzalez; Luz M Rodriguez; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-30

7.  Metabolism of exogenous S-adenosylmethionine in isolated rat hepatocyte suspensions: methylation of plasma-membrane phospholipids without intracellular uptake.

Authors:  F Bontemps; G Van Den Berghe
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

8.  Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers.

Authors:  P Giulidori; M Cortellaro; G Moreo; G Stramentinoli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 9.  S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

Authors:  Jin Gao; Catherine M Cahill; Xudong Huang; Joshua L Roffman; Stefania Lamon-Fava; Maurizio Fava; David Mischoulon; Jack T Rogers
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

10.  Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models.

Authors:  Bin Wu; Haiqing Cai; Shen Tang; Yilu Xu; Qianqian Shi; Lancheng Wei; Ling Meng; Ning Zhang; Xinhang Wang; Deqiang Xiao; Yunfeng Zou; Xiaobo Yang; Xiyi Li; Cailing Lu
Journal:  Neurotherapeutics       Date:  2020-09-21       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.